Three cases of psychosis after use of sacubitril/valsartan

Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):103-105. doi: 10.1016/j.rec.2020.05.033. Epub 2020 Jul 29.

[Article in English, Spanish]

Authors

Víctor Pérez-Roselló¹, María Batalla-Monedero², Ignacio Sánchez-Lázaro³, Raquel López-Vilella³, Pilar Sierra-San Miguel², Luis Almenar-Bonet³

Affiliations

¹ Servicio de Cardiología, Hospital Universitari i Politènic La Fe, Valencia, Spain. Electronic address: perez_vicrosa@gva.es.
² Servicio de Psiquiatría, Hospital Universitari i Politènic La Fe, Valencia, Spain.
³ Servicio de Cardiología, Hospital Universitari i Politènic La Fe, Valencia, Spain.

PMID: 32739142
DOI: 10.1016/j.rec.2020.05.033

No abstract available

Publication types

Case Reports

MeSH terms

Aminobutyrates / adverse effects
Angiotensin Receptor Antagonists / adverse effects
Biphenyl Compounds
Drug Combinations
Heart Failure* / chemically induced
Heart Failure* / drug therapy
Humans
Psychotic Disorders*
Tetrazoles / adverse effects
Valsartan

Substances

Aminobutyrates
Angiotensin Receptor Antagonists
Biphenyl Compounds
Drug Combinations
Tetrazoles
Valsartan
sacubitril and valsartan sodium hydrate drug combination